These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18579347)

  • 1. Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression.
    Domschke K; Dannlowski U; Ohrmann P; Lawford B; Bauer J; Kugel H; Heindel W; Young R; Morris P; Arolt V; Deckert J; Suslow T; Baune BT
    Eur Neuropsychopharmacol; 2008 Oct; 18(10):751-9. PubMed ID: 18579347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression.
    Baune BT; Dannlowski U; Domschke K; Janssen DG; Jordan MA; Ohrmann P; Bauer J; Biros E; Arolt V; Kugel H; Baxter AG; Suslow T
    Biol Psychiatry; 2010 Mar; 67(6):543-9. PubMed ID: 20044070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression.
    Domschke K; Dannlowski U; Hohoff C; Ohrmann P; Bauer J; Kugel H; Zwanzger P; Heindel W; Deckert J; Arolt V; Suslow T; Baune BT
    Eur Neuropsychopharmacol; 2010 May; 20(5):301-9. PubMed ID: 19854625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin receptor 1A-1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression?
    Baune BT; Hohoff C; Roehrs T; Deckert J; Arolt V; Domschke K
    Neurosci Lett; 2008 May; 436(2):111-5. PubMed ID: 18387740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic genes modulate amygdala activity in major depression.
    Dannlowski U; Ohrmann P; Bauer J; Kugel H; Baune BT; Hohoff C; Kersting A; Arolt V; Heindel W; Deckert J; Suslow T
    Genes Brain Behav; 2007 Oct; 6(7):672-6. PubMed ID: 17284168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Habitual emotion regulation strategies and depressive symptoms in healthy subjects predict fMRI brain activation patterns related to major depression.
    Abler B; Hofer C; Walter H; Erk S; Hoffmann H; Traue HC; Kessler H
    Psychiatry Res; 2010 Aug; 183(2):105-13. PubMed ID: 20630713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase A variant influences antidepressant treatment response in female patients with Major Depression.
    Domschke K; Hohoff C; Mortensen LS; Roehrs T; Deckert J; Arolt V; Baune BT
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):224-8. PubMed ID: 17884271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Event-related functional magnetic resonance imaging measures of neural activity to positive social stimuli in pre- and post-treatment depression.
    Schaefer HS; Putnam KM; Benca RM; Davidson RJ
    Biol Psychiatry; 2006 Nov; 60(9):974-86. PubMed ID: 16780808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia.
    Hamdani N; Tabeze JP; Ramoz N; Ades J; Hamon M; Sarfati Y; Boni C; Gorwood P
    Eur Neuropsychopharmacol; 2008 Jan; 18(1):34-40. PubMed ID: 17669634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
    Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
    Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional homogeneity in depression and its relationship with separate depressive symptom clusters: a resting-state fMRI study.
    Yao Z; Wang L; Lu Q; Liu H; Teng G
    J Affect Disord; 2009 Jun; 115(3):430-8. PubMed ID: 19007997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain effects of antidepressants in major depression: a meta-analysis of emotional processing studies.
    Delaveau P; Jabourian M; Lemogne C; Guionnet S; Bergouignan L; Fossati P
    J Affect Disord; 2011 Apr; 130(1-2):66-74. PubMed ID: 21030092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1).
    Barrero FJ; Ampuero I; Morales B; Vives F; de Dios Luna Del Castillo J; Hoenicka J; García Yébenes J
    Pharmacogenomics J; 2005; 5(2):135-41. PubMed ID: 15668727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
    Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
    Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortico-limbic response to personally challenging emotional stimuli after complete recovery from depression.
    Hooley JM; Gruber SA; Parker HA; Guillaumot J; Rogowska J; Yurgelun-Todd DA
    Psychiatry Res; 2009 Feb; 171(2):106-19. PubMed ID: 19176279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders.
    Witkin JM; Tzavara ET; Davis RJ; Li X; Nomikos GG
    Trends Pharmacol Sci; 2005 Dec; 26(12):609-17. PubMed ID: 16260047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression.
    Monteleone P; Bifulco M; Maina G; Tortorella A; Gazzerro P; Proto MC; Di Filippo C; Monteleone F; Canestrelli B; Buonerba G; Bogetto F; Maj M
    Pharmacol Res; 2010 May; 61(5):400-4. PubMed ID: 20080186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression.
    Frodl T; Koutsouleris N; Bottlender R; Born C; Jäger M; Mörgenthaler M; Scheuerecker J; Zill P; Baghai T; Schüle C; Rupprecht R; Bondy B; Reiser M; Möller HJ; Meisenzahl EM
    Mol Psychiatry; 2008 Dec; 13(12):1093-101. PubMed ID: 19008895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
    Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
    Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association of CNR1 gene variations with susceptibility to schizophrenia.
    Seifert J; Ossege S; Emrich HM; Schneider U; Stuhrmann M
    Neurosci Lett; 2007 Oct; 426(1):29-33. PubMed ID: 17881126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.